Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahsa Mohebtash

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Expert Opinion on Investigational Drugs|June 25, 2009
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancerRavi A Madan, Philip M Arlen, Mahsa Mohebtash, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 3, 2018
Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte GlobulinVarun Jain, Mahsa Mohebtash, Maria E Rodrigo, et al.
Cureus|October 25, 2017
Rectal Cancer in the Eye: A Case Report of Orbital MetastasisMohammed Nabeel, Rehan Farooqi, Mahsa Mohebtash, et al.
Expert Opinion on Biological Therapy|August 30, 2011
A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liverJames L Gulley, Ravi A Madan, Kwong-Yok Tsang, et al.
Contemporary Clinical Trials Communications|July 17, 2018
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancerFilipa Lynce, Mervat Saleh, Ayesha Shajahan-Haq, et al.
Breast Cancer Research and Treatment|October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxanePaula R Pohlmann, Deena Graham, Tianmin Wu, et al.
The Lancet. Oncology|February 14, 2012
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialRavi A Madan, Mahsa Mohebtash, Philip M Arlen, et al.
Cancer|June 22, 2021
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancerFilipa Lynce, Matthew J Blackburn, Rebecca Zhuo, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
JAMA Oncology|August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical TrialChristopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|June 25, 2009
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancerRavi A Madan, Philip M Arlen, Mahsa Mohebtash, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 3, 2018
Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte GlobulinVarun Jain, Mahsa Mohebtash, Maria E Rodrigo, et al.
Cureus|October 25, 2017
Rectal Cancer in the Eye: A Case Report of Orbital MetastasisMohammed Nabeel, Rehan Farooqi, Mahsa Mohebtash, et al.
Expert Opinion on Biological Therapy|August 30, 2011
A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liverJames L Gulley, Ravi A Madan, Kwong-Yok Tsang, et al.
Contemporary Clinical Trials Communications|July 17, 2018
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancerFilipa Lynce, Mervat Saleh, Ayesha Shajahan-Haq, et al.
Breast Cancer Research and Treatment|October 24, 2022
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxanePaula R Pohlmann, Deena Graham, Tianmin Wu, et al.
The Lancet. Oncology|February 14, 2012
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialRavi A Madan, Mahsa Mohebtash, Philip M Arlen, et al.
Cancer|June 22, 2021
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancerFilipa Lynce, Matthew J Blackburn, Rebecca Zhuo, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
JAMA Oncology|August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical TrialChristopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Pageof 3